Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 (4 (dimethylamino) 1 (4 fluorophenyl) 1 hydroxybutyl) 3 (hydroxymethyl) benzonitrile. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111533662B details a cost-effective synthesis of citalopram intermediates using accessible halogenated benzoic acids, offering significant supply chain advantages.